Avience Biomedicals IPO is scheduled to list on 25 Jun 2026 on NSE Emerge / BSE SME.
Listed
SME IPO
AVIENCE BOIMEDICALS
Avience Biomedicals IPO Listing Price Today
Avience Biomedicals IPO listed on 25 Jun 2026 at ₹395.2 against an issue price of ₹208, a listing gain of +90.00%.
- Issue price
- ₹208
- Actual listing price
- ₹395.2
- Listing Date
- 25 Jun 2026
- Exchange
- NSE Emerge / BSE SME
Live share price
Avience Biomedicals share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
Avience Biomedicals listing price vs GMP estimate
| Issue price | ₹208 |
|---|---|
| Latest GMP | ₹187.2 (+90.00%) |
| Expected listing price (issue price + GMP) | ₹395.2 |
| Actual listing price | ₹395.2 |
| Listing gain | +90.00% |
| Difference from GMP estimate | +₹0 (+0.00%) |
Profit per application
₹2,24,640
At the listing price, for 1,200 shares
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
Empirical GMP Accuracy:
Across 117 Indian IPOs, positive GMP predicted positive listing gains 69.8% of the time (35.6% of SME IPOs opened within 10% of their GMP estimate).
View Research Report →
GMP trend
Avience Biomedicals GMP trend before listing
| Date | GMP | Change |
|---|---|---|
| 23 Jun 2026 | ₹70.00 | - |
| 22 Jun 2026 | ₹70.00 | -15 |
| 19 Jun 2026 | ₹85.00 | +10 |
| 18 Jun 2026 | ₹75.00 | - |
Listing day
Listing day timings
| Listing Date | 25 Jun 2026 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | NSE Emerge / BSE SME |
FAQ
Avience Biomedicals IPO: frequently asked questions
Avience Biomedicals IPO listed at ₹395.2 against an issue price of ₹208, a listing gain of +90.00%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. Avience Biomedicals shares then start normal trading at 10:00 AM.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
At the listing price, one minimum application of 1,200 shares in Avience Biomedicals IPO made about ₹2,24,640.